MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Genetics"

  • MDS Virtual Congress 2021

    Molecular changes of a de novo missense variant in VPS16 in dystonia

    H. Pott, K. Zeuner, C. örün, S. Paschen, S. Diaw, K. Plötze-Martin, M. Borsche, G. Kuhlenbäumer, C. Klein, N. Brüggemann, M. Klinger, K. Lohmann (Lübeck, Germany)

    Objective: To present an early-onset dystonia patient with a de novo VPS16 missense variant, along with molecular characterization. Background: Mutations of the adaptor protein vacuolar…
  • MDS Virtual Congress 2021

    Pallidal Stimulation in children with monogenic dystonia

    A. Salazar Villacorta, M. Tardáguila, A. Bescós, K. Rosas, I. Delgado, L. Ispierto, R. álvarez, J. Muñoz, M. Poca, B. Pérez (Barcelona, Spain)

    Objective: To evaluate the efficacy and safety of Globus Pallidus Internus deep brain stimulation (GPi-DBS) in children with different forms of monogenic dystonia operated by…
  • MDS Virtual Congress 2021

    GPi-DBS for KMT2B-associated dystonia: systematic review and meta-analysis

    A. Saini (New Deelhi, India)

    Objective: To determine the efficacy of pallidal stimulation and GPi-DBS in KMT2B-associated dystonia. Background: Early evidence suggests good response to pallidal stimulation in KMT2B dystonia,…
  • MDS Virtual Congress 2021

    Deep Brain Stimulation in Confirmed Genetic Dystonias: A Comprehensive Review

    H. Sarva, F. Rodriguez-Porcel, S. Barkan, E. Gatto, P. Garcia Ruiz (New York, USA)

    Objective: Review DBS benefit in genetically confirmed dystonias. Background: Deep brain stimulation (DBS) is an established option for genetic dystonias such as DYT-1. While literature…
  • MDS Virtual Congress 2021

    Whole genome sequencing aids in diagnosing GCH1 dopa responsive dystonia in two Peruvian patients and influences medical management

    L. Urbina-Ramirez, J. La Serna-Infantes, E. Sarapura-Castro, A. Rivera-Valdivia, E. Thorpe, D. Perry, K. Milla-Neyra, C. Galarreta, M. Dueñas-Roque, M. Cornejo-Olivas (Lima, Peru)

    Objective: To describe the clinical features and treatment response of two Peruvian patients with GHC1 dopa responsive dystonia diagnosed by whole genome sequencing. Background: Pathogenic variants in…
  • MDS Virtual Congress 2021

    Diagnosis and management of Myoclonus Dystonia Syndrome: a Survey of the European Reference Network for Rare Neurological Diseases.

    M. Vanegas, E. Timmers, F. Hamami, S. Boesch, W. Vandenberghe, O. Burgazlieva, M. Møller, L. Hjermind, M. Vidailhet, A. Meneret, T. Bäumer, S. Siegert, T. Gasser, L. Schoels, J. Molnar, A. Capuano, F. Nicita, G. Zorzi, A. Albanese, A. Federico, E. Lohmann, J. Guk, M. Willemsen, N. Wolf, M. Dec-Cwiek, D. Neubauer, D. Flisar, V. Gonzalez, A. Darling, M. Marti, H. Houlden, C. Reinhard, A. Weissbach, M. Tijssen, B. Perez-Dueñas (Barcelona, Spain)

    Objective: To evaluate the diagnostic and treatment strategies in Myoclonus Dystonia Syndrome (MDS) used by experts from the European Reference Network for rare neurological diseases…
  • MDS Virtual Congress 2021

    MDSGene systematic review on dopa-responsive dystonia caused by mutations in GCH1, TH, SPR, PTS, or QDPR

    A. Weissbach, R. Herzog, M. Pauly, L. Hahn, I. König, S. Camargos, B. Jeon, M. Kurian, T. Opladen, N. Brüggemann, C. Klein, K. Lohmann (Lübeck, Germany)

    Objective: To systematically review information regarding genotype, phenotype, and biochemistry in dopa-responsive dystonia (DRD). Background: To date, five causative genes (GCH1, TH, SPR, PTS, and…
  • MDS Virtual Congress 2021

    A Child with Fever-Induced Paroxysmal Weakness and Encephalopathy with ATP1A3 mutation

    D. Ferman, Q. Luc (Los Angeles, USA)

    Objective: We describe a case of fever-induced paroxysmal weakness and encephalopathy (FIPWE), also known as relapsing encephalopathy with cerebellar ataxia (RECA) and expand the phenotypic…
  • MDS Virtual Congress 2020

    A case of generalized early-onset dystonia with a novel low-penetrant THAP1 missense variant

    I. Keller Sarmiento, A. Fraint, L. Kinsley, S. Lubbe, N. Mencacci, T. Simuni, D. Krainc (Chicago, IL, USA)

    Objective: To present a new case with generalized dystonia carrying a novel heterozygous likely pathogenic THAP1 variant associated with reduced penetrance Background: Dystonia is a…
  • MDS Virtual Congress 2020

    Recessive CWF19L1 mutations in a family with dystonia-ataxia syndrome

    S. Weber, M. Zech, S. Boesch, J. Winkelmann (Kassel, Germany)

    Objective: To enrich the limited clinical and genetic data of an extremely rare recessive ataxia subtype. Background: Advances in NGS techniques led to an increase…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley